This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.
Summary
Every clinical trial has eligibility criteria — a precise list of requirements that determine who can participate. These criteria protect participant safety, ensure the study population is appropriate for testing the intervention, and make results interpretable. Understanding how to read and navigate eligibility criteria significantly improves your ability to find a trial you qualify for.
Inclusion Criteria: Who the Trial Is For
Inclusion criteria define the characteristics a participant must have to enroll. They typically include:
- Age range: "18–75 years" or "adults ≥18 years" — some trials specifically target older adults or pediatric populations
- Diagnosis: Specific condition with defined diagnostic criteria (ICD code, clinical criteria, or biomarker confirmation)
- Disease stage or severity: "HbA1c 7.5–11.0%," "NYHA Class II–III," "ECOG performance status 0–1"
- Prior treatment: "Must have received at least one prior line of systemic therapy" or "Treatment-naïve patients only"
- Laboratory values: Adequate organ function defined by specific thresholds (eGFR ≥45, ALT ≤2× ULN)
- Biomarker requirements: PD-L1 positive, BRCA-mutated, amyloid-positive on PET
Exclusion Criteria: Safety and Scientific Reasons
Exclusion criteria remove people who would be at increased risk from trial participation or whose data would confound results:
- Safety exclusions: Pregnancy (teratogenicity risk), active serious infection, severe organ impairment, history of severe allergic reactions
- Drug interaction exclusions: Medications that interact with the study drug via the same metabolic pathway (CYP3A4 inhibitors/inducers)
- Competing interventions: Recent surgery, recent major cardiovascular event, recent receipt of another investigational drug
- Scientific exclusions: Conditions that would make the primary endpoint uninterpretable (e.g., excluding patients with other causes of the measured outcome)
The Trend Toward Broader Eligibility
Historically, trials were criticized for overly restrictive eligibility criteria that excluded elderly patients, people with common comorbidities, and racial/ethnic minorities — resulting in drugs approved based on populations that don't represent real-world patients. FDA guidance issued in 2020–2023 actively encouraged sponsors to broaden eligibility, particularly for oncology trials.
In 2026, you'll see more trials enrolling patients with stable comorbidities (controlled hypertension, mild-moderate kidney disease), patients over 75, and patients on stable background medications that would previously have been excluded. This makes trials more accessible and results more generalizable.
What to Do If You Don't Qualify
Not qualifying for one trial doesn't mean you can't participate in any trial. Strategies include:
- Search for similar trials with different eligibility windows — HbA1c cutoffs, staging criteria, and washout periods vary between studies of the same drug class
- Ask the research coordinator if your exclusion is absolute or potentially waivable — some exclusions allow exceptions with medical documentation
- Optimize your health before re-screening — if excluded for a lab value, work with your physician to address it
- Ask about expanded access (compassionate use) programs for drugs still in trials
- Check for Phase 4 or observational studies, which typically have much broader eligibility than interventional trials